- £620.93m
- £801.75m
- €1.67bn
- 54
- 59
- 67
- 67
Annual income statement for C&C, fiscal year end - February 28th, EUR millions except per share, conversion factor applied.
2021 February 28th | 2022 February 28th | R2023 February 28th | 2024 February 29th | 2025 February 28th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 737 | 1,438 | 1,686 | 1,653 | 1,666 |
Cost of Revenue | |||||
Gross Profit | 168 | 332 | 395 | 381 | — |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 824 | 1,382 | 1,617 | 1,742 | 1,625 |
Operating Profit | -86.9 | 56.5 | 68.9 | -89.6 | 40.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -121 | 45.7 | 52.2 | -112 | 19.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -105 | 37.1 | 40.3 | -114 | 13.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -105 | 37.1 | 40.3 | -114 | 13.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -105 | 37.1 | 40.3 | -114 | 13.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.218 | 0.022 | 0.144 | 0.106 | 0.144 |
Dividends per Share |